Abstract
Pharmaceutical inhalation aerosol technology has become an important therapy for the treatment of both respiratory and non-respiratory illness. Targeting therapeutic aerosols to the small airways of the lung can effectively treat many of these diseases. Delivery of the therapeutic agent directly to the site of action, for cases involving respiratory diseases, ensures an adequate therapeutic level of the drug is reached, without leading to side effects due to high systemic concentrations. For non-respiratory diseases, the periphery of the lung offers enormous surface area (approximately 100m2) for rapid absorption into circulation. In either case, the appropriate spray characteristics (0.5 um
Library of Congress Subject Headings
Turbulence; Nozzles--Fluid dynamics; Fluid mechanics; Spraying; Atomization; Aerosol therapy
Publication Date
2002
Document Type
Thesis
Department, Program, or Center
Mechanical Engineering (KGCOE)
Advisor
Robinson, Risa
Advisor/Committee Member
Wellin, John
Advisor/Committee Member
Kozak, Jeffrey
Recommended Citation
Medlar, Michael, "Analysis of the droplet size reduction in a pMDI to the addition of a turbulence generating nozzle" (2002). Thesis. Rochester Institute of Technology. Accessed from
https://repository.rit.edu/theses/7254
Campus
RIT – Main Campus
Comments
Note: imported from RIT’s Digital Media Library running on DSpace to RIT Scholar Works. Physical copy available through RIT's The Wallace Library at: TA357 .M435 2002